Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants

Simple item page
dc.contributor.authorRahimi, Farid
dc.contributor.authorAbadi, Amin Talebi Bezmin
dc.date.accessioned2023-04-17T01:56:58Z
dc.date.available2023-04-17T01:56:58Z
dc.date.issued2021
dc.date.updated2022-01-23T07:19:09Z
dc.description.abstractDocumenting the vaccine type, its booster dosing, target populations, optimal dosing intervals and the vaccination timeline is crucial for determining the vaccine effectiveness against the existing or new SARS-CoV-2 variants. Any change in the future statistics of COVID-19 may help us better understand the virus and its potential seasonally emerging variants akin to the seasonal flu or measles.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1746-0794en_AU
dc.identifier.urihttp://hdl.handle.net/1885/289304
dc.language.isoen_AUen_AU
dc.provenancehttps://v2.sherpa.ac.uk/id/publication/12298/..."published version can be archived in institutional repository" from SHERPA/RoMEO site as at 17/04/2023en_AU
dc.publisherFuture Science Groupen_AU
dc.rights© 2021 The authorsen_AU
dc.sourceFuture Virologyen_AU
dc.subjectbooster immunizationen_AU
dc.subjectCOVID-19 vaccinesen_AU
dc.subjectpandemicen_AU
dc.subjectSARS-CoV-2 variantsen_AU
dc.titleThe third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variantsen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue12en_AU
local.bibliographicCitation.lastpage784en_AU
local.bibliographicCitation.startpage781en_AU
local.contributor.affiliationRahimi, Farid, College of Science, ANUen_AU
local.contributor.affiliationAbadi, Amin Talebi Bezmin, Tarbiat Modares Universityen_AU
local.contributor.authoruidRahimi, Farid, u4885897en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor320705 - Medical virologyen_AU
local.identifier.absfor420202 - Disease surveillanceen_AU
local.identifier.absseo200499 - Public health (excl. specific population health) not elsewhere classifieden_AU
local.identifier.ariespublicationu5399821xPUB19en_AU
local.identifier.citationvolume16en_AU
local.identifier.doi.2217/fvl-2021-0240en_AU
local.publisher.urlhttps://www.futuremedicine.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
fvl-2021-0240.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2026 LYRASIS